the glutamatergic system
Showing 1 - 25 of >10,000
Tourette Syndrome Trial in Toulouse (Experimental MRI exam and PET scan exam with radiotracer)
Recruiting
- Tourette Syndrome
- Experimental MRI exam and PET scan exam with radiotracer
-
Toulouse, FranceHôpital Pierre-Paul Riquet - CHU Toulouse
Aug 26, 2021
Resistant Schizophrenia: A Longitudinal Magnetic Resonance
Active, not recruiting
- Schizophrenia
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 2, 2022
MDD Trial in Rochester (NeuroStar TMS Therapy® System, NeuroStar XPLOR®)
Active, not recruiting
- Major Depressive Disorder
- NeuroStar TMS Therapy® System
- NeuroStar XPLOR®
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 3, 2023
Glutamatergic and GABAergic System in Schizophrenia
Not yet recruiting
- Schizophrenia
- Genotyping
-
Aachen, Northrine-Westphalia, Germany
- +2 more
Jul 24, 2021
DRACULA1 Partum Depression:Integrated Molecular-pharmaco-imaging
Not yet recruiting
- Post-partum Depression
-
Milan, MI, ItalyFondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Nov 8, 2023
Mental Disorder Trial in France (immunomodulatory treatment by rituximab)
Not yet recruiting
- Mental Disorder
- immunomodulatory treatment by rituximab
-
Bordeaux, France
- +8 more
Jul 7, 2023
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Glutamatergic Changes in Rapid Antidepressant Effects of Sleep
Not yet recruiting
- Major Depressive Disorder
- Sleep Deprivation
- (no location specified)
May 30, 2023
Cocaine Use Disorder, Cocaine Dependence Trial in Zürich (Ketamine, Placebo, real-time fMRI neurofeedback training)
Not yet recruiting
- Cocaine Use Disorder
- Cocaine Dependence
- Ketamine
- +3 more
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich, University of Zurich
Nov 6, 2023
Cortical Excitability, Psychiatric Disorder Trial in Providence (L-theanine, Placebo)
Completed
- Cortical Excitability
- Psychiatric Disorder
- L-theanine
- Placebo
-
Providence, Rhode IslandButler Hospital
Aug 30, 2021
OCD Trial (Memantine Oral Tablet, Placebo)
Not yet recruiting
- Obsessive-Compulsive Disorder
- Memantine Oral Tablet
- Placebo
- (no location specified)
Aug 19, 2021
Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())
Recruiting
- Treatment Resistant Depression
- +2 more
- Ketamine Hydrochloride
- No intervention (placebo)
-
Oxford, United KingdomDepartment of Psychiatry, University of Oxford
Mar 28, 2023
ADHD Trial in Wayne (AEVI-001, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- AEVI-001
- Placebo
-
Wayne, PennsylvaniaAevi Genomic Medicine
Jul 2, 2021
Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)
Completed
- Familial Alcoholism Vulnerability
- Mavoglurant (AFQ056)
- Placebo
-
Hartford, ConnecticutHartford Hospital
Jan 7, 2022
Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)
Suspended
- Disorder of Consciousness
- Traumatic Brain Injury
- Amantadine + L-DOPA
- NMDA blocker
-
New York, New YorkWeill Cornell Medicine
Sep 27, 2022
Heroin Abuse, Opioid Use Disorder, Substance-Related Disorders Trial in New York (Cannabidiol (CBD), Placebo)
Active, not recruiting
- Heroin Abuse
- +3 more
- Cannabidiol (CBD)
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 29, 2022
ADHD Trial in Taipei county (Aerobic exercise, Video-watching)
Recruiting
- Attention Deficit Hyperactivity Disorder
- Aerobic exercise
- Video-watching
-
Taipei county, TaiwanNeurophysiology and Cognition in Children and Young Adults Lab,
Nov 8, 2023
Post Treatment Lyme Syndrome (PTLS), Chronic Pain Trial in New York (Milnacipran and D-cycloserine)
Terminated
- Post Treatment Lyme Syndrome
- +2 more
- Milnacipran with D-cycloserine augmentation
- Milnacipran with placebo augmentation
- (no location specified)
Sep 14, 2021
Psychosis Trial in Albuquerque (Lumateperone, Risperidone)
Recruiting
- Psychosis
-
Albuquerque, New MexicoUniversity of New Mexico
May 25, 2023
Inhibitory Neurotransmission in the Human Epileptic Brain.
Recruiting
- Drug Resistant Epilepsy
- ex-vivo study
-
Pozzilli, Isernia, ItalyIRCCS INM Neuromed
Jul 29, 2022
Healthy Trial in New York (Ketamine Hydrochloride)
Active, not recruiting
- Healthy
- Ketamine Hydrochloride
-
New York, New YorkNew York State Psychiatric
Jan 3, 2023
OCD Trial in Dhaka (N-acetylcysteine tablet 600mg, Placebo tablet 600mg)
Recruiting
- OCD
- N-acetylcysteine tablet 600mg
- Placebo tablet 600mg
-
Dhaka, Bangladesh
- +1 more
Nov 14, 2021
Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T
Recruiting
- Gilles de la Tourette Syndrome
- Tourette Syndrome
- MRI scanner (7 Tesla)
-
Leipzig, GermanyMax Planck Institute for Human Cognitive and Brain Sciences
Feb 10, 2022